Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABSORB Bioresorbable Scaffold vs. Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis

NCT02486068 is registered in ClinicalTrials.gov with European Cardiovascular Research Center as lead sponsor.

NCT NCT02486068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02486068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABSORB Bioresorbable Scaffold vs. Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis
Lead sponsor
European Cardiovascular Research Center
Phase
Not applicable
Overall status
Unknown status
Start date
September 28, 2015
Completion date
September 30, 2024
Enrollment
1,670 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery lesion